Live Science: In a 1st, trial finds vitamin D supplements may slow multiple sclerosis. But questions remain.
In a 1st, trial finds vitamin D supplements may slow multiple sclerosis. But questions remain.
FierceBiotech: Roche reports another phase 3 multiple sclerosis win, but deaths add to safety questions
Roche reports another phase 3 multiple sclerosis win, but deaths add to safety questions
Medical Xpress: Q&A: Why are women more likely to develop multiple sclerosis? A proteomics study provides clues
Knowing that women are diagnosed with multiple sclerosis (MS) at three times the rate of men, particularly during their 30s and 40s, scientists in the CU Anschutz lab of Kimberley Bruce, Ph.D., ...
Q&A: Why are women more likely to develop multiple sclerosis? A proteomics study provides clues
Multiple sclerosis isn’t inherited, but having a family member with the disease can increase your chance of having the condition. While genetics influences your risk, environmental factors also play a ...
Science Daily: New study finds a promising combined therapy for multiple sclerosis
Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials, focusing on ...
The New England Journal of Medicine: Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple sclerosis ...
The Conversation: Out‑of‑balance bacteria is linked to multiple sclerosis − the ratio can predict severity of disease